Milacron Holdings Corp. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2018. For the quarter, the company reported net sales were $328.1 million against $309.2 million a year ago. Operating earnings was $35.2 million against $28.9 million a year ago. Earnings before income taxes were $23.3 million against $18.2 million a year ago. Net earnings were $14.9 million against $10.1 million a year ago. Diluted earnings per share were $0.21 against $0.14 a year ago. Net cash provided by operating activities was $14.5 million against $7.3 million a year ago. Purchases of property and equipment were $8.6 million against $12.3 million a year ago. Adjusted EBITDA was $62.8 million against $59.6 million a year ago. Adjusted diluted earnings per share were $0.48 against $0.46 a year ago. Adjusted net income was $34.2 million against $32.6 million a year ago. The second quarter growth was primarily driven by the MDCS and Fluids segments as company had several strategic portfolio actions, as previously mentioned by Tom, which impacted company's APPT revenue and growth rates.

For the period, the company reported net sales were $638.5 million against $594.6 million a year ago. Operating earnings was $58.3 million against $48.9 million a year ago. Earnings before income taxes were $35.1 million against $0.3 million a year ago. Net income was $20.8 million against net loss of $14.5 million a year ago. Diluted income per share was $0.29 against diluted loss per share of $0.21 a year ago. Net cash provided in operating activities was $22.1 million against net cash used in operating activities of $1.4 million a year ago. Purchases of property and equipment were $15.9 million against $25 million a year ago. Adjusted EBITDA was $118.2 million against $109.6 million a year ago. Adjusted diluted earnings per share were $0.87 against $0.78 a year ago. Net debt of $743.8 million. Adjusted net income was $62.6 million against $55.2 million a year ago.

The company revised the earnings guidance for the full Year of 2018. For the full year, the company forecasts 2.0% to 4.0% organic sales growth in 2018, which is inclusive of an anticipated 1.0% foreign currency tailwind. Adjusted EBITDA is forecasted to be between $237 million and $240 million. Free Cash Flow is forecasted to be between $80 million and $90 million. The company expects capital expenditures $45 million.